GSWM
AUPH icon

Golden State Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Golden State Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.9K Hold
263
– – ﹤0.01% 1254
2025
Q4 		$4.2K Hold
263
– – ﹤0.01% 1271
2025
Q3 		$2.91K Hold
263
– – ﹤0.01% 1340
2025
Q2 		$2.23K Hold
263
– – ﹤0.01% 1345
2025
Q1 		$2.12K Hold
263
– – ﹤0.01% 1309
2024
Q4 		$2.36K Buy
+263
New +$2.15K ﹤0.01% 1233
2020
Q2 		– Sell
-450
Closed -$7K – 250
2020
Q1 		$7K Buy
+450
New +$7.94K ﹤0.01% 676

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return